Literature DB >> 18853831

Extracorporeal tubing in the roller pump raceway: physical changes and particulate generation.

Allison J Bednarski Spiwak1, Alexander Horbal, Robert Leatherbury, Derek J Hansford.   

Abstract

Plasticized polyvinyl chloride tubing is used as the blood conduit in the heart lung bypass circuit. The section in the roller pump undergoes rigorous compression. Fatigue leads to material changes in weight and length of the bulk material. Particles are released during normal pump operation. This study evaluates the time course of particle loss. Three segments of 1/2" ID tubing run in the raceway for 30-minute, 1-hour, or 2-hour. The fluid path of each segment includes an oxygenator; a castor oil blend was used for the prime. The 5 mL sample was acquired at 10 minute intervals. Raceway tubing segments were measured for a change in weight and length. The same procedure repeated with 1/4" ID and 3/8" ID tubing. All tubing increased at least 5 mm by the 2-hour trial. There were no remarkable changes in weight. Particles were measured for size and percent volume. Tubing with 1/2" ID performed most consistently for particle release during all trials. Particles were observed as small as 1 nm. Particles as large as 3 micron could be confirmed. For all tubing there was particle release by 30 minutes. Perfusionists must consider tubing inner diameter and wall thickness in choosing the pPVC for the raceway in order to minimize particulate emboli. This research suggests that 3/8" ID tubing produces spalls inconsistently compared to 2" ID tubing. Thinner wall thickness tubing also has the potential to limit spall formation.

Entities:  

Mesh:

Year:  2008        PMID: 18853831      PMCID: PMC4680645     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  16 in total

1.  Blood surfaces in the extra corporeal circuit: a scanning electron microscopic study. 1975.

Authors:  Mark Kurusz; Dennis R Williams
Journal:  J Extra Corpor Technol       Date:  2004-03

2.  Investigation of fatigue failure of S-65-HL "Super Tygon" roller pump tubing.

Authors:  E J Snyder; D L McElwee; H M Harb; J A Cullen; I S Tackel; S Baumgart; B Iskandarani; A Elkind; M Shaker
Journal:  J Extra Corpor Technol       Date:  1996-06

3.  Measurement of RBC deformation and velocity in capillaries in vivo.

Authors:  Jae Hong Jeong; Yasusiko Sugii; Motomu Minamiyama; Koji Okamoto
Journal:  Microvasc Res       Date:  2006-04-19       Impact factor: 3.514

4.  Sedative clearance during extracorporeal membrane oxygenation.

Authors:  Varsha Bhatt-Meht; Gail Annich
Journal:  Perfusion       Date:  2005-10       Impact factor: 1.972

Review 5.  Biomaterial development for cardiopulmonary bypass.

Authors:  T Gourlay
Journal:  Perfusion       Date:  2001-09       Impact factor: 1.972

6.  Intravenous exposure to di(2-ethylhexyl)phthalate (DEHP): metabolites of DEHP in urine after a voluntary platelet donation.

Authors:  Holger M Koch; Hermann M Bolt; Ralf Preuss; Reinhold Eckstein; Volker Weisbach; Jürgen Angerer
Journal:  Arch Toxicol       Date:  2005-07-30       Impact factor: 5.153

7.  Migration resistant, blood-compatible plasticized polyvinyl chloride for medical and related applications.

Authors:  S Lakshmi; A Jayakrishnan
Journal:  Artif Organs       Date:  1998-03       Impact factor: 3.094

8.  Insulin binding to the cardiopulmonary bypass biomaterials.

Authors:  Kristyn Urban; Daniel Redford; Douglas F Larson
Journal:  Perfusion       Date:  2007-05       Impact factor: 1.972

9.  Investigation of the release behavior of diethylhexyl phthalate from the polyvinyl-chloride tubing for intravenous administration.

Authors:  T Hanawa; E Muramatsu; K Asakawa; M Suzuki; M Tanaka; K Kawano; T Seki; K Juni; S Nakajima
Journal:  Int J Pharm       Date:  2000-12-04       Impact factor: 5.875

10.  Presence of plasticizer di-2(ethylhexyl)phthalate in primed extracorporeal circulation circuits.

Authors:  Harold M Burkhart; Nitasha Joyner; Scott Niles; Jay Ploessl; Jeff Everett; Mark Iannettoni; Wayne Richenbacher
Journal:  ASAIO J       Date:  2007 May-Jun       Impact factor: 2.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.